Skip to content
value.today
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. is listed today as Minerva Neurosciences, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Minerva Neurosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2016$1 MPrivate placement after listingUnder $2 million

Minerva Neurosciences, Inc.: Private sale, Mar 2016

Investors in this round

1 investor had bought by the notice of Mar 18, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Fred Ahlholm · Executive Officer
  • Geoff Race · Executive Officer
  • Joseph Reilly · Executive Officer
  • Mark Levine · Executive Officer
  • Remy Luthringer · Executive Officer, Director
  • David Kupfer · Director
  • Fouzia Laghrissi-Thode · Director
  • Francesco De Rubertis · Director
  • Jan Van Heek · Director
  • Marc Beer · Director
  • Michele Ollier · Director
  • Nico Vandervelpen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Levine, Senior Vice President, General Counsel & Secretary. Source: SEC Form D, newest notice filed Mar 18, 2016. Read the notice at the SEC.

equitySEC
Mar 2015$31 MPrivate placement after listing$10 to $50 million

Minerva Neurosciences, Inc.: Private sale, Mar 2015

Investors in this round

22 investors had bought by the notice of Mar 24, 2015: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $31 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,170,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Fred Ahlholm · Executive Officer
  • Geoff Race · Executive Officer
  • Joseph Reilly · Executive Officer
  • Mark Levine · Executive Officer
  • Remy Luthringer · Executive Officer, Director
  • Francesco De Rubertis · Director
  • Jan Van Heek · Director
  • Marc Beer · Director
  • Michele Ollier · Director
  • Nico Vandervelpen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Jefferies LLC (CRD 2347) · New York, New YorkSold in all US states

Signed by Mark Levine, VP, General Counsel & Secretary. Source: SEC Form D, newest notice filed Mar 24, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Minerva Neurosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2016).

    SEC Form D · Mar 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2016

That is all the official record says: Minerva Neurosciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Minerva Neurosciences, Inc. are on record.

Investors#

No investor of Minerva Neurosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Minerva Neurosciences, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Minerva Neurosciences, Inc.
NameRoleNamed in
Fred AhlholmExecutive officerMar 2016
Geoff RaceExecutive officerMar 2016
Joseph ReillyExecutive officerMar 2016
Mark LevineExecutive officerMar 2016
Remy LuthringerExecutive officerMar 2016
David KupferDirectorMar 2016
Fouzia Laghrissi-ThodeDirectorMar 2016
Francesco De RubertisDirectorMar 2016
Jan Van HeekDirectorMar 2016
Marc BeerDirectorMar 2016
Michele OllierDirectorMar 2016
Nico VandervelpenDirectorMar 2016
Remy LuthringerDirectorMar 2016

About

Company in Waltham, United States.

Went public since 2014. Its SEC number is that of a company listed on a stock exchange.